chevron_leftBack
As of 6 June 2026, Sapporo Clinical Laboratory Inc. has a market cap of $38.05M USD, ranking #32545 globally and #3070 in Japan.
It ranks #2941 in the Healthcare sector, and #52 in the Pharmaceutical Retailers industry.
Key Stats
Market Cap
$38.05MUSD
6.09B JPY
Enterprise Value
$29.29MUSD
4.69B JPY
Revenue (TTM)
$127.42MUSD
20.39B JPY
EBITDA (TTM)
$8.13MUSD
1.3B JPY
Net Income (TTM)
$2.41MUSD
386.0M JPY
EBITDA Margin
6.4%
Profit Margin
1.9%
PE Ratio
15.8
PS Ratio
0.3
PB Ratio
0.5
EV/EBITDA
3.6
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Pharmaceutical Retailers
CEO
Tadamasa Date
open_in_new
Employees
879
Founded
1965
Website
saturin.co.jp
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.4% | -0.4% | -0.7% | 0.1% | 84% | 93% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
9776
札幌臨床検査センター株式会社
ISIN: JP3321100004
Shares Out.:
Shares Outstanding:
3.12M1
Shares Float:
765.343K2
|
1,952 JPY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Sapporo Clinical Laboratory Inc.
Sapporo Clinical Laboratory Inc. operates dispensing pharmacies in Japan. The company engages in contract and agency services for various clinical testing and public health testing, as well as food hygiene testing; sales and maintenance of software, such as clinical testing systems; management of dispensing pharmacies; and pharmaceutical wholesale. It also offers pathological examination, holter testing, radiation management, clinic opening support, test result inquiry services, and electronic medical record linkage. The company was incorporated in 1965 and is headquartered in Sapporo, Japan.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TSE: 3391
|
$6.09B
16K%
974.65B JPY
|
14.9
|
|
TSE: 3088
|
$5.9B
15K%
944.48B JPY
|
16.9
|
|
TSE: 3141
|
$4.11B
11K%
657.73B JPY
|
34.2
|
|
TSE: 7649
|
$3.67B
10K%
587.26B JPY
|
13.1
|
|
TSE: 3349
|
$3.09B
8K%
494.8B JPY
|
15.8
|
|
TSE: 9989
|
$2.76B
7K%
441.38B JPY
|
14.2
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: CVS
|
$107.53B
282K%
|
58.3
|
|
SHEK: 6618
|
$18.59B
49K%
145.64B HKD
|
24.3
|
|
NASDAQ: WBA
|
$10.37B
27K%
|
-
|
|
BVMF: RADL3
|
$7.45B
19K%
38.53B BRL
|
28.2
|
|
SSE: 603939
|
$4.16B
11K%
28.13B CNY
|
16.6
|
|
JSE: CLS
|
$3.78B
10K%
61.66B ZAR
|
18.7
|
chevron_leftBack